Budesonide combined inhalation of terbutaline treatment AECOPD 30 Cases

Objective Budesonide combined inhalation of terbutaline in chronic obstructive pulmonary disease ( AECOPD) in clinical efficacy. Methods 60 patients with AECOPD inpatients were randomly divided into two groups and the control group. 30 cases observed in the routine treatment given Budesonide 2 mg and terbutaline aerosol saline solution plus 2 ml 5 mg combined inhalation therapy,2 times / day; the control group of 30 patients,on the basis of routine treatment given to give terbutaline atomization treatment 5 mg plus 2 ml normal saline,2 times / day,7 days after the two groups of patients the clinical symptoms of drug use,blood gas analysis and the first second percentage of total estimated value of expiratory volume ( FEV1% predicted value) changes were compared. Results Both before and after treatment PaO2,PaCO2,FEV1% predicted value,the difference was statistically significant ( P 0. 05) ,between the two groups compared with the corresponding indicators,the differences were statistically significant ( P 0. 05). Two groups in age,gender,onset,duration and other similar composition. Conclusion budesonide inhalation of terbutaline on AECOPD rapid remission of disease,respiratory flow,improve lung function,more effective than single agent,is the treatment of AECOPD are effective choice.